oral glp-1 drugs New Guidelines for Type 2 Diabetes in 2025 The First Oral GLP-1 Pill

This guide examines peer-reviewed research on EVOO and GLP-1 secretion, hydroxytyrosol and insulin sensitivity, oleocanthal and inflammation, and why these olive-specific compounds are distinct from other dietary polyphenols

Incretin mimetics considerably expanded their proven benefits beyond obesity in 2024

95% CI 0.90, 1.01) and cerebrovascular events (HR 0.99

Tirzepatide), metabolic outcomes, and next-gen weight loss benefits

Background Bariatric surgery (BS) is the most effective treatment for severe obesity, but a significant proportion of patients experience insufficient weight loss (IWL) or weight regain

This comprehensive review explores the mechanisms, clinical implications, and mitigation strategies, including exercise, protein intake, and adjunct therapies.